If You Invested in Charlies Holdings Inc (CHUC)

Charlie's Holdings, Inc. (OTCQB: CHUC) operates in the premium vapor products space within the broader manufacturing sector. According to recent company disclosures, Charlie's focuses on vapor products that are designed for adult consumers and are distributed through a subsidiary, Charlie's Chalk Dust, LLC. The company describes itself as an industry leader in premium vapor products, with offerings that are sold around the world to select distributors, specialty retailers, and third-party online resellers.

Charlie's business centers on branded vapor product lines that include SBX, PACHA, and Pachamama 25K. The company highlights a portfolio of brand styles, flavor profiles, and various product formats developed under Charlie's Chalk Dust, LLC. In its public communications, Charlie's emphasizes non-nicotine SBX products, synthetic nicotine PACHA products that are subject to Premarket Tobacco Product Applications (PMTAs), and Pachamama 25K products that can be produced in a domestic manufacturing facility.

Business focus and product strategy

The company reports that its SBX line is a non-nicotine product category aimed at adults who use conventional vape products or combustible cigarettes and who want the taste and sensation of traditional flavored nicotine products in a different format. Charlie's states that SBX products are legal across most of the United States and that early SBX sales in several regions have exceeded internal expectations. Management commentary describes SBX as a major contributor to revenue growth and as a key driver of retail distribution in convenience stores.

Charlie's also reports activity around its PACHA-branded Electronic Nicotine Delivery Systems (ENDS) and synthetic nicotine products. The company has pursued PMTA submissions for a large portfolio of products and has entered into strategic partnerships involving PMTA asset sales. These PMTA-related transactions have generated income for the company and are described as part of a broader strategy to realize monetary and strategic value from the PMTA portfolio.

The Pachamama 25K product line is another focus area. Charlie's has opened a U.S. manufacturing facility in Huntington Beach, California, dedicated to filling its own brands, including Pachamama 25K. The company notes that this domestic manufacturing capability is intended to meet new domestic manufacturing requirements in large states such as Texas, where legislation restricts certain imported vape products. By offering U.S.-filled products, Charlie's positions its Pachamama 25K line as compliant with these requirements and appealing to adult consumers who prefer products made in the United States.

Distribution and market channels

Charlie's states that its products are sold globally through a network of select distributors, specialty retailers, and third-party online resellers. Within the United States, the company has emphasized growth in the convenience store channel. It has reported successful introductions of SBX in multiple states and has referenced purchase orders from regional convenience store chains and distribution partners, including significant sales activity at industry trade shows such as the National Association of Convenience Stores (NACS) National Show.

The company has also highlighted that SBX products are being rolled out in phases, starting with strategically selected states and expanding to additional regions and chains. Management commentary links this distribution expansion to increased revenue and to the company's broader growth trajectory.

Regulatory and compliance orientation

Regulatory compliance and youth access prevention are recurring themes in Charlie's public statements. The company has reported efforts to develop and deploy age-gating technology for certain products, particularly in connection with SBX and PACHA-branded ENDS devices. In partnership with IKE Tech LLC, Charlie's has entered into a licensing agreement to integrate an AI-powered, blockchain-based age-gating system into its nicotine analogue and ENDS product lines.

According to the company and its partner, this age-gating system uses Bluetooth Low Energy chips and biometric authentication through a web or app interface to control device activation and prevent underage use. A human factors validation study cited in company communications reported that underage users were unable to activate devices, and that adult users were able to complete age verification successfully. Charlie's describes this technology as a way to address regulatory concerns related to youth access and as a potential competitive advantage in markets where regulators are focused on flavored vapor products.

In addition to age-gating, Charlie's has emphasized its PMTA portfolio and related regulatory filings with the U.S. Food and Drug Administration. The company reports that it has received FDA acceptance for a large number of PMTAs and that it has begun to monetize certain PMTA assets through sales to strategic buyers. Management commentary characterizes these assets as having substantial potential value and as central to the company's long-term regulatory and commercial strategy.

Manufacturing and operational footprint

Charlie's has described a shift toward U.S.-based manufacturing for select product lines. The company opened a domestic manufacturing facility in Huntington Beach, California, for filling its own brands, including Pachamama 25K disposables. This facility is intended to address shipping delays and tariff costs associated with overseas manufacturing and to comply with domestic manufacturing requirements in states that restrict products manufactured or marketed as coming from certain foreign jurisdictions.

The company has indicated that, at times, it plans to devote all of its U.S. manufacturing capacity to meeting demand in specific markets, such as Texas, where new laws have created opportunities for compliant, domestically filled vapor products. This operational decision is presented as a response to both regulatory changes and market demand.

Financial and capital structure notes

In its public news releases, Charlie's has reported periods of profitability and revenue growth, including quarters in which net income was positive and revenue increased compared with prior-year periods. The company has also described efforts to reduce debt and to improve its balance sheet, including the elimination of certain notes payable.

To support inventory purchases and growth in the convenience store channel, Charlie's entered into a credit facility with an independent member of its board of directors. The company characterizes this facility as favorable and notes that it is not convertible to equity and does not include warrants. Management commentary links this financing to the need to meet demand for SBX products while avoiding more dilutive or expensive forms of capital.

Charlie’s has also filed regulatory documents with the U.S. Securities and Exchange Commission. For example, a Form 12b-25 (Notification of Late Filing) was submitted in connection with a Quarterly Report on Form 10-Q for the period ended September 30, 2025. In that filing, the company stated that it required additional time for compilation and review to ensure adequate disclosure and anticipated filing the Form 10-Q within the permitted extension period.

Strategic focus and corporate positioning

Across its communications, Charlie's emphasizes several strategic themes: growth in non-nicotine SBX products, monetization and licensing of its PMTA portfolio, expansion of domestic manufacturing, and development of age-gating technology for flavored vapor products. The company has also announced the planned discontinuation of hemp/CBD-related product sales and the closure of its Don Polly division. This decision is described as a step toward facilitating a potential uplist to a national securities exchange and removing trading restrictions associated with hemp/CBD-related activities.

Management commentary frequently references goals such as expanding the shareholder base, increasing liquidity, and positioning the company for a potential uplist. The company has participated in investor conferences and industry trade shows to present its products and strategy to investors and retail partners.